{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T02:25:24Z","timestamp":1789871124860,"version":"4.0.1"},"publisher-location":"Cham","reference-count":134,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783031663550","type":"print"},{"value":"9783031663567","type":"electronic"}],"license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1007\/7854_2023_451","type":"book-chapter","created":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T00:01:35Z","timestamp":1699833695000},"page":"149-174","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Psilocybin and Other Classic Psychedelics in Depression"],"prefix":"10.1007","author":[{"given":"D. J.","family":"Nutt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. M.","family":"Peill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Godfrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. L.","family":"Carhart-Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Erritzoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,14]]},"reference":[{"key":"451_CR1","unstructured":"Abuse S (2021) Key substance use and mental health indicators in the United States: results from the 2020 National Survey on Drug Use and Health (HHS Publication No. PEP21-07-01-003, NSDUH Series H-56)"},{"issue":"4","key":"451_CR2","first-page":"59","volume":"10","author":"S Adamson","year":"1988","unstructured":"Adamson S, Metzner R (1988) The nature of the MDMA experience and its role in healing, psychotherapy and spiritual practice. Revision 10(4):59\u201372","journal-title":"Revision"},{"issue":"2","key":"451_CR3","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1021\/acsptsci.1c00014","volume":"4","author":"JS Aday","year":"2021","unstructured":"Aday JS, Davis AK, Mitzkovitz CM, Bloesch EK, Davoli CC (2021) Predicting reactions to psychedelic drugs: a systematic review of states and traits related to acute drug effects. ACS Pharmacol Transl Sci 4(2):424\u2013435","journal-title":"ACS Pharmacol Transl Sci"},{"key":"451_CR4","doi-asserted-by":"crossref","unstructured":"Aday JS, Heifets BD, Pratscher SD, Bradley E, Rosen R, Woolley JD (2022) Great expectations: recommendations for improving the methodological rigor of psychedelic clinical trials. Psychopharmacology (Berl):1\u201322","DOI":"10.31234\/osf.io\/nrb3t"},{"issue":"3","key":"451_CR5","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1177\/02698811221080165","volume":"36","author":"G Agin-Liebes","year":"2022","unstructured":"Agin-Liebes G, Zeifman R, Luoma JB, Garland EL, Campbell WK, Weiss B (2022) Prospective examination of the therapeutic role of psychological flexibility and cognitive reappraisal in the ceremonial use of ayahuasca. J Psychopharmacol 36(3):295\u2013308","journal-title":"J Psychopharmacol"},{"issue":"11","key":"451_CR6","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1177\/0269881115609019","volume":"29","author":"FS Barrett","year":"2015","unstructured":"Barrett FS, Johnson MW, Griffiths RR (2015) Validation of the revised mystical experience questionnaire in experimental sessions with psilocybin. J Psychopharmacol 29(11):1182\u20131190","journal-title":"J Psychopharmacol"},{"issue":"6","key":"451_CR7","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","volume":"4","author":"AT Beck","year":"1961","unstructured":"Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4(6):561\u2013571","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"451_CR8","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1093\/ijnp\/pyac075","volume":"26","author":"AM Becker","year":"2023","unstructured":"Becker AM, Klaiber A, Holze F, Istampoulouoglou I, Duthaler U, Varghese N, Eckert A, Liechti ME (2023) Ketanserin reverses the acute response to LSD in a randomized, double-blind, placebo-controlled, crossover study in healthy participants. Int J Neuropsychopharmacol 26(2):97\u2013106. https:\/\/doi.org\/10.1093\/ijnp\/pyac075","journal-title":"Int J Neuropsychopharmacol"},{"issue":"4","key":"451_CR9","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1177\/0022167817706884","volume":"57","author":"AB Belser","year":"2017","unstructured":"Belser AB, Agin-Liebes G, Swift TC, Terrana S, Devenot N, Friedman HL, Guss J, Bossis A, Ross S (2017) Patient experiences of psilocybin-assisted psychotherapy: an interpretative phenomenological analysis. J Humanist Psychol 57(4):354\u2013388","journal-title":"J Humanist Psychol"},{"key":"451_CR506","doi-asserted-by":"publisher","unstructured":"Butler M, Jelen L, Rucker J (2022) Expectancy in placebo-controlled trials of psychedelics: if so, so what? Psychopharmacology (Berl) 239(10):3047\u20133055. https:\/\/doi.org\/10.1007\/s00213-022-06221-6. PMCID: PMC9481484. PMID: 36063208","DOI":"10.1007\/s00213-022-06221-6"},{"issue":"12","key":"451_CR10","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1177\/0269881116662634","volume":"30","author":"TM Carbonaro","year":"2016","unstructured":"Carbonaro TM, Bradstreet MP, Barrett FS, MacLean KA, Jesse R, Johnson MW, Griffiths RR (2016) Survey study of challenging experiences after ingesting psilocybin mushrooms: acute and enduring positive and negative consequences. J Psychopharmacol 30(12):1268\u20131278","journal-title":"J Psychopharmacol"},{"issue":"3","key":"451_CR11","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1124\/pr.118.017160","volume":"71","author":"RL Carhart-Harris","year":"2019","unstructured":"Carhart-Harris RL, Friston K (2019) REBUS and the anarchic brain: toward a unified model of the brain action of psychedelics. Pharmacol Rev 71(3):316\u2013344","journal-title":"Pharmacol Rev"},{"issue":"15","key":"451_CR12","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1056\/NEJMoa2032994","volume":"384","author":"R Carhart-Harris","year":"2021","unstructured":"Carhart-Harris R, Giribaldi B, Watts R, Baker-Jones M, Murphy-Beiner A, Murphy R, Martell J, Blemings A, Erritzoe D, Nutt DJ (2021) Trial of psilocybin versus escitalopram for depression. N Engl J Med 384(15):1402\u20131411. https:\/\/doi.org\/10.1056\/NEJMoa2032994","journal-title":"N Engl J Med"},{"key":"451_CR13","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.neuropharm.2018.03.010","volume":"142","author":"RL Carhart-Harris","year":"2018","unstructured":"Carhart-Harris RL (2018) The entropic brain-revisited. Neuropharmacology 142:167\u2013178","journal-title":"Neuropharmacology"},{"issue":"9","key":"451_CR14","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1177\/0269881117725915","volume":"31","author":"RL Carhart-Harris","year":"2017","unstructured":"Carhart-Harris RL, Nutt DJ (2017) Serotonin and brain function: a tale of two receptors. J Psychopharmacol 31(9):1091\u20131120. https:\/\/doi.org\/10.1177\/0269881117725915","journal-title":"J Psychopharmacol"},{"issue":"3","key":"451_CR15","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1192\/bjp.bp.111.103309","volume":"200","author":"RL Carhart-Harris","year":"2012","unstructured":"Carhart-Harris RL, Leech R, Williams T, Erritzoe D, Abbasi N, Bargiotas T, Hobden P, Sharp D, Evans J, Feilding A (2012) Implications for psychedelic-assisted psychotherapy: functional magnetic resonance imaging study with psilocybin. Br J Psychiatry 200(3):238\u2013244","journal-title":"Br J Psychiatry"},{"key":"451_CR16","doi-asserted-by":"crossref","unstructured":"Carhart-Harris RL, Leech R, Hellyer PJ, Shanahan M, Feilding A, Tagliazucchi E, Chialvo DR, Nutt D (2014) The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs. Front Hum Neurosci 20","DOI":"10.3389\/fnhum.2014.00020"},{"key":"451_CR17","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s00213-014-3714-z","volume":"232","author":"RL Carhart-Harris","year":"2015","unstructured":"Carhart-Harris RL, Kaelen M, Whalley M, Bolstridge M, Feilding A, Nutt DJ (2015) LSD enhances suggestibility in healthy volunteers. Psychopharmacology (Berl) 232:785\u2013794","journal-title":"Psychopharmacology (Berl)"},{"issue":"7","key":"451_CR18","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S2215-0366(16)30065-7","volume":"3","author":"RL Carhart-Harris","year":"2016","unstructured":"Carhart-Harris RL, Bolstridge M, Rucker J, Day CM, Erritzoe D, Kaelen M, Bloomfield M, Rickard JA, Forbes B, Feilding A (2016a) Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. Lancet Psychiatry 3(7):619\u2013627","journal-title":"Lancet Psychiatry"},{"issue":"17","key":"451_CR19","doi-asserted-by":"crossref","first-page":"4853","DOI":"10.1073\/pnas.1518377113","volume":"113","author":"RL Carhart-Harris","year":"2016","unstructured":"Carhart-Harris RL, Muthukumaraswamy S, Roseman L, Kaelen M, Droog W, Murphy K, Tagliazucchi E, Schenberg EE, Nest T, Orban C (2016b) Neural correlates of the LSD experience revealed by multimodal neuroimaging. Proc Natl Acad Sci 113(17):4853\u20134858","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"451_CR20","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00213-017-4771-x","volume":"235","author":"RL Carhart-Harris","year":"2018","unstructured":"Carhart-Harris RL, Bolstridge M, Day C, Rucker J, Watts R, Erritzoe D, Kaelen M, Giribaldi B, Bloomfield M, Pilling S (2018a) Psilocybin with psychological support for treatment-resistant depression: six-month follow-up. Psychopharmacology (Berl) 235(2):399\u2013408","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"451_CR21","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s00213-017-4771-x","volume":"235","author":"RL Carhart-Harris","year":"2018","unstructured":"Carhart-Harris RL, Bolstridge M, Day CMJ, Rucker J, Watts R, Erritzoe DE, Kaelen M, Giribaldi B, Bloomfield M, Pilling S, Rickard JA, Forbes B, Feilding A, Taylor D, Curran HV, Nutt DJ (2018b) Psilocybin with psychological support for treatment-resistant depression: six-month follow-up. Psychopharmacology (Berl) 235(2):399\u2013408. https:\/\/doi.org\/10.1007\/s00213-017-4771-x","journal-title":"Psychopharmacology (Berl)"},{"key":"451_CR22","doi-asserted-by":"crossref","unstructured":"Carhart-Harris R, Chandaria S, Erritzoe D, Gazzaley A, Girn M, Kettner H, Mediano P, Nutt D, Rosas F, Roseman L (2022) Canalization and plasticity in psychopathology. Neuropharmacology:109398","DOI":"10.1016\/j.neuropharm.2022.109398"},{"issue":"2","key":"451_CR23","first-page":"16","volume":"6","author":"E Cascade","year":"2009","unstructured":"Cascade E, Kalali AH, Kennedy SH (2009) Real-world data on SSRI antidepressant side effects. Psychiatry (Edgmont) 6(2):16","journal-title":"Psychiatry (Edgmont)"},{"issue":"4","key":"451_CR24","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1176\/appi.focus.16407","volume":"16","author":"A Cipriani","year":"2018","unstructured":"Cipriani A, Furukawa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y, Leucht S, Ruhe HG, Turner EH, Higgins JP (2018) Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Focus 16(4):420\u2013429","journal-title":"Focus"},{"key":"451_CR25","volume-title":"Surfing uncertainty: prediction, action, and the embodied mind","author":"A Clark","year":"2015","unstructured":"Clark A (2015) Surfing uncertainty: prediction, action, and the embodied mind. Oxford University Press"},{"key":"451_CR26","doi-asserted-by":"crossref","unstructured":"Clark A (2016) Attention alters predictive processing. Behav Brain Sci 39","DOI":"10.1017\/S0140525X15002472"},{"issue":"4","key":"451_CR27","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/j.1743-6109.2007.00520.x","volume":"4","author":"A Clayton","year":"2007","unstructured":"Clayton A, Kornstein S, Prakash A, Mallinckrodt C, Wohlreich M (2007) Psychology: changes in sexual functioning associated with duloxetine, escitalopram, and placebo in the treatment of patients with major depressive disorder. J Sex Med 4(4):917\u2013929","journal-title":"J Sex Med"},{"key":"451_CR28","doi-asserted-by":"crossref","unstructured":"Close JB, Hajien EC, Watts R, Roseman L, Carhart-Harris RL (2020) Psychedelics and psychological flexibility\u2013results of a prospective web-survey using the acceptance and action questionnaire II. J Contextual Behav Sci","DOI":"10.1016\/j.jcbs.2020.01.005"},{"key":"451_CR29","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cpr.2015.05.001","volume":"40","author":"AA Cooper","year":"2015","unstructured":"Cooper AA, Conklin LR (2015) Dropout from individual psychotherapy for major depression: A meta-analysis of randomized clinical trials. Clin Psychol Rev 40:57\u201365","journal-title":"Clin Psychol Rev"},{"issue":"9","key":"451_CR30","doi-asserted-by":"crossref","first-page":"401","DOI":"10.4088\/JCP.09r05021","volume":"70","author":"P Cuijpers","year":"2009","unstructured":"Cuijpers P, Dekker J, Hollon SD, Andersson G (2009) Adding psychotherapy to pharmacotherapy in the treatment of depressive disorders in adults: a meta-analysis. J Clin Psychiatry 70(9):401","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"451_CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1472-6963-10-181","volume":"10","author":"P Cuijpers","year":"2010","unstructured":"Cuijpers P, van Straten A, Warmerdam L, van Rooy MJ (2010) Recruiting participants for interventions to prevent the onset of depressive disorders: Possible ways to increase participation rates. BMC Health Serv Res 10(1):1\u20136","journal-title":"BMC Health Serv Res"},{"issue":"4","key":"451_CR32","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1017\/S0033291713000457","volume":"44","author":"P Cuijpers","year":"2014","unstructured":"Cuijpers P, Turner E, Mohr D, Hofmann S, Andersson G, Berking M, Coyne J (2014) Comparison of psychotherapies for adult depression to pill placebo control groups: a meta-analysis. Psychol Med 44(4):685\u2013695","journal-title":"Psychol Med"},{"issue":"5","key":"451_CR33","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1001\/jamapsychiatry.2020.3285","volume":"78","author":"AK Davis","year":"2021","unstructured":"Davis AK, Barrett FS, May DG, Cosimano MP, Sepeda ND, Johnson MW, Finan PH, Griffiths RR (2021a) Effects of psilocybin-assisted therapy on major depressive disorder: a randomized clinical trial. JAMA Psychiatry 78(5):481\u2013489. https:\/\/doi.org\/10.1001\/jamapsychiatry.2020.3285","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"451_CR34","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1177\/0269881120967878","volume":"35","author":"AK Davis","year":"2021","unstructured":"Davis AK, Barrett FS, So S, Gukasyan N, Swift TC, Griffiths RR (2021b) Development of the psychological insight questionnaire among a sample of people who have consumed psilocybin or LSD. J Psychopharmacol 35(4):437\u2013446","journal-title":"J Psychopharmacol"},{"issue":"4","key":"451_CR35","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/s41591-022-01744-z","volume":"28","author":"RE Daws","year":"2022","unstructured":"Daws RE, Timmermann C, Giribaldi B, Sexton JD, Wall MB, Erritzoe D, Roseman L, Nutt D, Carhart-Harris R (2022) Increased global integration in the brain after psilocybin therapy for depression. Nat Med 28(4):844\u2013851. https:\/\/doi.org\/10.1038\/s41591-022-01744-z","journal-title":"Nat Med"},{"issue":"1","key":"451_CR36","doi-asserted-by":"publisher","first-page":"16392","DOI":"10.1038\/s41598-020-73216-8","volume":"10","author":"MK Doss","year":"2020","unstructured":"Doss MK, May DG, Johnson MW, Clifton JM, Hedrick SL, Prisinzano TE, Griffiths RR, Barrett FS (2020) The acute effects of the atypical dissociative hallucinogen Salvinorin A on functional connectivity in the human brain. Sci Rep 10(1):16392. https:\/\/doi.org\/10.1038\/s41598-020-73216-8","journal-title":"Sci Rep"},{"key":"451_CR37","doi-asserted-by":"crossref","unstructured":"Drummond E, McCulloch W, Knudsen GM, Barrett FS, Doss MK, Carhart-Harris RL, Rosas FE, Deco G, Kringelbach ML, Preller KH (2022) Psychedelic resting-state neuroimaging: a review and perspective on balancing replication and novel analyses. Neurosci Biobehav Rev:104689","DOI":"10.1016\/j.neubiorev.2022.104689"},{"issue":"10","key":"451_CR503","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1038\/s41386-022-01344-y","volume":"47","author":"DC D\u2019Souza","year":"2022","unstructured":"D\u2019Souza DC, Syed SA, Flynn LT, Safi-Aghdam H, Cozzi NV, Ranganathan M (2022) Exploratory study of the dose-related safety, tolerability, and efficacy of dimethyltryptamine (DMT) in healthy volunteers and major depressive disorder. Neuropsychopharmacology 47(10):1854\u20131862. https:\/\/doi.org\/10.1038\/s41386-022-01344-y. Epub 2022 Jun 3. PMID: 35660802. PMCID: PMC9372173","journal-title":"Neuropsychopharmacology"},{"issue":"9","key":"451_CR38","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1177\/0269881119827891","volume":"33","author":"D Erritzoe","year":"2019","unstructured":"Erritzoe D, Smith J, Fisher PM, Carhart-Harris R, Frokjaer VG, Knudsen GM (2019) Recreational use of psychedelics is associated with elevated personality trait openness: exploration of associations with brain serotonin markers. J Psychopharmacol 33(9):1068\u20131075","journal-title":"J Psychopharmacol"},{"issue":"5","key":"451_CR501","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1111\/acps.12904","volume":"138","author":"D Erritzoe","year":"2018","unstructured":"Erritzoe D, Roseman L, NourMM MLK, Kaelen M, Nutt DJ, Carhart-Harris RL (2018) Effects of psilocybin therapy on personality structure. Acta Psychiatr Scand 138(5):368\u2013378. https:\/\/doi.org\/10.1111\/acps.12904. Epub 2018 Jun 19. PMID: 29923178. PMCID: PMC6220878","journal-title":"Acta Psychiatr Scand"},{"issue":"11","key":"451_CR39","doi-asserted-by":"publisher","first-page":"e0242056","DOI":"10.1371\/journal.pone.0242056","volume":"15","author":"N Farnes","year":"2020","unstructured":"Farnes N, Juel BE, Nilsen AS, Romundstad LG, Storm JF (2020) Increased signal diversity\/complexity of spontaneous EEG, but not evoked EEG responses, in ketamine-induced psychedelic state in humans. PloS One 15(11):e0242056. https:\/\/doi.org\/10.1371\/journal.pone.0242056","journal-title":"PloS One"},{"issue":"2","key":"451_CR40","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/nrn2787","volume":"11","author":"K Friston","year":"2010","unstructured":"Friston K (2010) The free-energy principle: a unified brain theory? Nat Rev Neurosci 11(2):127\u2013138","journal-title":"Nat Rev Neurosci"},{"issue":"1521","key":"451_CR41","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1098\/rstb.2008.0300","volume":"364","author":"K Friston","year":"2009","unstructured":"Friston K, Kiebel S (2009) Predictive coding under the free-energy principle. Philos Trans R Soc B Biol Sci 364(1521):1211\u20131221","journal-title":"Philos Trans R Soc B Biol Sci"},{"issue":"10","key":"451_CR42","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1177\/0269881120936486","volume":"34","author":"NL Galv\u00e3o-Coelho","year":"2020","unstructured":"Galv\u00e3o-Coelho NL, de Menezes Galv\u00e3o AC, de Almeida RN, Palhano-Fontes F, Campos Braga I, Lob\u00e3o Soares B, Maia-de-Oliveira JP, Perkins D, Sarris J, de Araujo DB (2020) Changes in inflammatory biomarkers are related to the antidepressant effects of Ayahuasca. J Psychopharmacol 34(10):1125\u20131133. https:\/\/doi.org\/10.1177\/0269881120936486","journal-title":"J Psychopharmacol"},{"key":"451_CR43","doi-asserted-by":"crossref","unstructured":"Girn M, Rosas FE, Daws RE, Gallen CL, Gazzaley A, Carhart-Harris RL (2023) A complex systems perspective on psychedelic brain action. Trends Cogn Sci","DOI":"10.1016\/j.tics.2023.01.003"},{"issue":"18","key":"451_CR44","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1056\/NEJMoa2206443","volume":"387","author":"GM Goodwin","year":"2022","unstructured":"Goodwin GM, Aaronson ST, Alvarez O, Arden PC, Baker A, Bennett JC, Bird C, Blom RE, Brennan C, Brusch D (2022a) Single-dose psilocybin for a treatment-resistant episode of major depression. N Engl J Med 387(18):1637\u20131648","journal-title":"N Engl J Med"},{"issue":"18","key":"451_CR45","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1056\/NEJMoa2206443","volume":"387","author":"GM Goodwin","year":"2022","unstructured":"Goodwin, G. M., Aaronson, S. T., Alvarez, O., Arden, P. C., Baker, A., Bennett, J. C., Bird, C., Blom, R. E., Brennan, C., Brusch, D., Burke, L., Campbell-Coker, K., Carhart-Harris, R., Cattell, J., Daniel, A., DeBattista, C., Dunlop, B. W., Eisen, K., Feifel, D., . . . Malievskaia, E. (2022b). Single-dose psilocybin for a treatment-resistant episode of major depression. N Engl J Med, 387(18), 1637\u20131648. https:\/\/doi.org\/10.1056\/NEJMoa2206443","journal-title":"N Engl J Med"},{"key":"451_CR46","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s11606-011-1704-y","volume":"26","author":"JL Grenard","year":"2011","unstructured":"Grenard JL, Munjas BA, Adams JL, Suttorp M, Maglione M, McGlynn EA, Gellad WF (2011) Depression and medication adherence in the treatment of chronic diseases in the United States: a meta-analysis. J Gen Intern Med 26:1175\u20131182","journal-title":"J Gen Intern Med"},{"issue":"12","key":"451_CR47","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1177\/0269881116675513","volume":"30","author":"RR Griffiths","year":"2016","unstructured":"Griffiths RR, Johnson MW, Carducci MA, Umbricht A, Richards WA, Richards BD, Cosimano MP, Klinedinst MA (2016) Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial. J Psychopharmacol 30(12):1181\u20131197. https:\/\/doi.org\/10.1177\/0269881116675513","journal-title":"J Psychopharmacol"},{"issue":"3","key":"451_CR502","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1159\/000467984","volume":"8","author":"S Grof","year":"1973","unstructured":"Grof S, Goodman LE, Richards WA, Kurland AA (1973) LSD-assisted psychotherapy in patients with terminal cancer. Int Pharmacopsychiatry 8(3):129\u2013144. https:\/\/doi.org\/10.1159\/000467984","journal-title":"Int Pharmacopsychiatry"},{"issue":"2","key":"451_CR48","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1177\/02698811211073759","volume":"36","author":"N Gukasyan","year":"2022","unstructured":"Gukasyan N, Davis AK, Barrett FS, Cosimano MP, Sepeda ND, Johnson MW, Griffiths RR (2022) Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: prospective 12-month follow-up. J Psychopharmacol 36(2):151\u2013158","journal-title":"J Psychopharmacol"},{"issue":"1","key":"451_CR49","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","volume":"23","author":"M Hamilton","year":"1960","unstructured":"Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23(1):56","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"451_CR50","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/s2215-0366(17)30015-9","volume":"4","author":"CJ Harmer","year":"2017","unstructured":"Harmer CJ, Duman RS, Cowen PJ (2017) How do antidepressants work? New perspectives for refining future treatment approaches. Lancet Psychiatry 4(5):409\u2013418. https:\/\/doi.org\/10.1016\/s2215-0366(17)30015-9","journal-title":"Lancet Psychiatry"},{"issue":"12","key":"451_CR51","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1177\/0269881116677852","volume":"30","author":"I Hartogsohn","year":"2016","unstructured":"Hartogsohn I (2016) Set and setting, psychedelics and the placebo response: an extra-pharmacological perspective on psychopharmacology. J Psychopharmacol 30(12):1259\u20131267","journal-title":"J Psychopharmacol"},{"key":"451_CR52","doi-asserted-by":"crossref","unstructured":"Hohwy J, Seth A (2020) Predictive processing as a systematic basis for identifying the neural correlates of consciousness. Philos Mind Sci 1(II)","DOI":"10.33735\/phimisci.2020.II.64"},{"issue":"3","key":"451_CR53","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.biopsych.2022.08.025","volume":"93","author":"F Holze","year":"2023","unstructured":"Holze F, Gasser P, M\u00fcller F, Dolder PC, Liechti ME (2023) Lysergic acid diethylamide-assisted therapy in patients with anxiety with and without a life-threatening illness: a randomized, double-blind, placebo-controlled phase II study. Biol Psychiatry 93(3):215\u2013223. https:\/\/doi.org\/10.1016\/j.biopsych.2022.08.025","journal-title":"Biol Psychiatry"},{"key":"451_CR54","unstructured":"Hyde RW (1960) Psychological and social determinants of drug action. The dynamics of psychiatric drug therapy, pp 297\u2013315"},{"issue":"6","key":"451_CR55","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1177\/0269881108093587","volume":"22","author":"MW Johnson","year":"2008","unstructured":"Johnson MW, Richards WA, Griffiths RR (2008) Human hallucinogen research: guidelines for safety. J Psychopharmacol 22(6):603\u2013620","journal-title":"J Psychopharmacol"},{"issue":"19","key":"451_CR56","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1007\/s00213-015-4014-y","volume":"232","author":"M Kaelen","year":"2015","unstructured":"Kaelen M, Barrett FS, Roseman L, Lorenz R, Family N, Bolstridge M, Curran HV, Feilding A, Nutt DJ, Carhart-Harris R (2015) LSD enhances the emotional response to music. Psychopharmacology (Berl) 232(19):3607\u20133614","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"451_CR57","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00213-017-4820-5","volume":"235","author":"M Kaelen","year":"2018","unstructured":"Kaelen M, Giribaldi B, Raine J, Evans L, Timmerman C, Rodriguez N, Roseman L, Feilding A, Nutt D, Carhart-Harris R (2018) The hidden therapist: evidence for a central role of music in psychedelic therapy. Psychopharmacology (Berl) 235(2):505\u2013519","journal-title":"Psychopharmacology (Berl)"},{"key":"451_CR58","doi-asserted-by":"crossref","unstructured":"Kangaslampi S (2023) Association between mystical-type experiences under psychedelics and improvements in well-being or mental health \u2013 a comprehensive review of the evidence. J Psychedelic Stud","DOI":"10.1556\/2054.2023.00243"},{"key":"451_CR59","doi-asserted-by":"crossref","unstructured":"Kettner H, Rosas F, Timmermann C, K\u00e4rtner L, Carhart-Harris RL, Roseman L (2021) Psychedelic communitas: intersubjective experience during psychedelic group sessions predicts enduring changes in psychological wellbeing and social connectedness. Front Pharmacol:234","DOI":"10.3389\/fphar.2021.623985"},{"issue":"3","key":"451_CR60","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/wps.20241","volume":"14","author":"A Khan","year":"2015","unstructured":"Khan A, Brown WA (2015) Antidepressants versus placebo in major depression: an overview. World Psychiatry 14(3):294\u2013300","journal-title":"World Psychiatry"},{"key":"451_CR61","doi-asserted-by":"publisher","first-page":"661233","DOI":"10.3389\/fpsyt.2021.661233","volume":"12","author":"R Ko\u010d\u00e1rov\u00e1","year":"2021","unstructured":"Ko\u010d\u00e1rov\u00e1 R, Hor\u00e1\u010dek J, Carhart-Harris R (2021) Does psychedelic therapy have a transdiagnostic action and prophylactic potential? Front Psych 12:661233. https:\/\/doi.org\/10.3389\/fpsyt.2021.661233","journal-title":"Front Psych"},{"issue":"9","key":"451_CR62","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1002\/hbm.23234","volume":"37","author":"AV Lebedev","year":"2016","unstructured":"Lebedev AV, Kaelen M, L\u00f6vd\u00e9n M, Nilsson J, Feilding A, Nutt DJ, Carhart-Harris RL (2016) LSD-induced entropic brain activity predicts subsequent personality change. Hum Brain Mapp 37(9):3203\u20133213","journal-title":"Hum Brain Mapp"},{"key":"451_CR63","doi-asserted-by":"crossref","unstructured":"Lepow L, Morishita H, Yehuda R (2021) Critical period plasticity as a framework for psychedelic-assisted psychotherapy. Front Neurosci:1165","DOI":"10.3389\/fnins.2021.710004"},{"key":"451_CR64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroscience.2022.08.007","volume":"501","author":"N Li","year":"2022","unstructured":"Li N, Jin D, Wei J, Huang Y, Xu J (2022) Functional brain abnormalities in major depressive disorder using a multiscale community detection approach. Neuroscience 501:1\u201310","journal-title":"Neuroscience"},{"key":"451_CR65","doi-asserted-by":"crossref","first-page":"102760","DOI":"10.1016\/j.concog.2019.05.008","volume":"73","author":"M Lifshitz","year":"2019","unstructured":"Lifshitz M, van Elk M, Luhrmann TM (2019) Absorption and spiritual experience: a review of evidence and potential mechanisms. Conscious Cogn 73:102760","journal-title":"Conscious Cogn"},{"issue":"11","key":"451_CR66","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1177\/0269881111420188","volume":"25","author":"KA MacLean","year":"2011","unstructured":"MacLean KA, Johnson MW, Griffiths RR (2011) Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness. J Psychopharmacol 25(11):1453\u20131461","journal-title":"J Psychopharmacol"},{"issue":"7","key":"451_CR67","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1038\/s41386-019-0324-9","volume":"44","author":"MK Madsen","year":"2019","unstructured":"Madsen MK, Fisher PM, Burmester D, Dyssegaard A, Stenb\u00e6k DS, Kristiansen S, Johansen SS, Lehel S, Linnet K, Svarer C (2019) Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels. Neuropsychopharmacology 44(7):1328\u20131334","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"451_CR68","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41398-021-01335-5","volume":"11","author":"N Mason","year":"2021","unstructured":"Mason N, Kuypers K, Reckweg J, M\u00fcller F, Tse D, Da Rios B, Toennes S, Stiers P, Feilding A, Ramaekers J (2021) Spontaneous and deliberate creative cognition during and after psilocybin exposure. Transl Psychiatry 11(1):209","journal-title":"Transl Psychiatry"},{"issue":"5","key":"451_CR69","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.biopsych.2009.11.001","volume":"67","author":"C McCabe","year":"2010","unstructured":"McCabe C, Mishor Z, Cowen PJ, Harmer CJ (2010) Diminished neural processing of aversive and rewarding stimuli during selective serotonin reuptake inhibitor treatment. Biol Psychiatry 67(5):439\u2013445","journal-title":"Biol Psychiatry"},{"issue":"2","key":"451_CR70","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1177\/0269881119895520","volume":"34","author":"LJ Mertens","year":"2020","unstructured":"Mertens LJ, Wall MB, Roseman L, Demetriou L, Nutt DJ, Carhart-Harris RL (2020) Therapeutic mechanisms of psilocybin: changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression. J Psychopharmacol 34(2):167\u2013180. https:\/\/doi.org\/10.1177\/0269881119895520","journal-title":"J Psychopharmacol"},{"key":"451_CR71","first-page":"3","volume":"5","author":"R Metzner","year":"1965","unstructured":"Metzner R, Litwin G, Weil G (1965) The relation of expectation and mood to psilocybin reactions: a questionnaire study. Psychedelic Rev 5:3\u201339","journal-title":"Psychedelic Rev"},{"issue":"9","key":"451_CR72","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1007\/s00213-019-05249-5","volume":"236","author":"MC Mithoefer","year":"2019","unstructured":"Mithoefer MC, Feduccia AA, Jerome L, Mithoefer A, Wagner M, Walsh Z, Hamilton S, Klosinski B, Emerson A, Doblin R (2019) MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials. Psychopharmacology (Berl) 236(9):2735\u20132745","journal-title":"Psychopharmacology (Berl)"},{"issue":"4","key":"451_CR73","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","volume":"134","author":"SA Montgomery","year":"1979","unstructured":"Montgomery SA, \u00c5sberg M (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry 134(4):382\u2013389","journal-title":"Br J Psychiatry"},{"key":"451_CR74","unstructured":"Morgese MG, Chrobak AA, Jiang C, Maroteaux L, Romay-Tallon R, Sowa-Ku\u0107ma M, Stachowicz K, Sowa-Ku\u0107ma M (2023) The treatment of depression searching for new ideas. The pharmacotherapy of depression-searching for new mechanisms and drug interactions. Basic and clinical research, 16648714, p 153"},{"key":"451_CR75","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.nicl.2018.03.005","volume":"18","author":"F M\u00fcller","year":"2018","unstructured":"M\u00fcller F, Dolder PC, Schmidt A, Liechti ME, Borgwardt S (2018) Altered network hub connectivity after acute LSD administration. Neuroimage Clin 18:694\u2013701. https:\/\/doi.org\/10.1016\/j.nicl.2018.03.005","journal-title":"Neuroimage Clin"},{"key":"451_CR76","doi-asserted-by":"crossref","unstructured":"Murphy R, Kettner H, Zeifman R, Giribaldi B, Kartner L, Martell J, Read T, Murphy-Beiner A, Baker-Jones M, Nutt D (2022) Therapeutic alliance and rapport modulate responses to psilocybin assisted therapy for depression. Front Pharmacol 3819","DOI":"10.3389\/fphar.2021.788155"},{"key":"451_CR77","doi-asserted-by":"publisher","unstructured":"Murphy RJ, Sumner R, Evans W, Ponton R, Ram S, Godfrey K, Forsyth A, Cavadino A, Krishmamuthy V, Smith T, Hoeh NR, Menkes DB, Muthukumaraswamy S (2023) Acute mood-elevating properties of microdosed LSD in healthy volunteers: a home-administered randomised controlled trial. Biol Psychiatry. https:\/\/doi.org\/10.1016\/j.biopsych.2023.03.013","DOI":"10.1016\/j.biopsych.2023.03.013"},{"issue":"38","key":"451_CR78","doi-asserted-by":"crossref","first-page":"15171","DOI":"10.1523\/JNEUROSCI.2063-13.2013","volume":"33","author":"SD Muthukumaraswamy","year":"2013","unstructured":"Muthukumaraswamy SD, Carhart-Harris RL, Moran RJ, Brookes MJ, Williams TM, Errtizoe D, Sessa B, Papadopoulos A, Bolstridge M, Singh KD (2013a) Broadband cortical desynchronization underlies the human psychedelic state. J Neurosci 33(38):15171\u201315183","journal-title":"J Neurosci"},{"issue":"38","key":"451_CR79","doi-asserted-by":"publisher","first-page":"15171","DOI":"10.1523\/JNEUROSCI.2063-13.2013","volume":"33","author":"SD Muthukumaraswamy","year":"2013","unstructured":"Muthukumaraswamy SD, Carhart-Harris RL, Moran RJ, Brookes MJ, Williams TM, Errtizoe D, Sessa B, Papadopoulos A, Bolstridge M, Singh KD, Feilding A, Friston KJ, Nutt DJ (2013b) Broadband cortical desynchronization underlies the human psychedelic state. J Neurosci 33(38):15171\u201315183. https:\/\/doi.org\/10.1523\/JNEUROSCI.2063-13.2013","journal-title":"J Neurosci"},{"key":"451_CR80","doi-asserted-by":"crossref","unstructured":"Muthukumaraswamy S, Forsyth A, Sumner RL (2022) The challenges ahead for psychedelic \u2018medicine\u2019. Aust N Z J Psychiatry:00048674221081763","DOI":"10.1177\/00048674221081763"},{"key":"451_CR81","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3389\/fphar.2018.00132","volume":"9","author":"EM Nielson","year":"2018","unstructured":"Nielson EM, May DG, Forcehimes AA, Bogenschutz MP (2018) The psychedelic debriefing in alcohol dependence treatment: illustrating key change phenomena through qualitative content analysis of clinical sessions. Front Pharmacol 9:132","journal-title":"Front Pharmacol"},{"issue":"7","key":"451_CR82","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1177\/0269881118780612","volume":"32","author":"T Noorani","year":"2018","unstructured":"Noorani T, Garcia-Romeu A, Swift TC, Griffiths RR, Johnson MW (2018) Psychedelic therapy for smoking cessation: qualitative analysis of participant accounts. J Psychopharmacol 32(7):756\u2013769","journal-title":"J Psychopharmacol"},{"key":"451_CR83","doi-asserted-by":"crossref","unstructured":"Nour MM, Evans L, Nutt D, Carhart-Harris RL (2016) Ego-dissolution and psychedelics: validation of the ego-dissolution inventory (EDI). Front Hum Neurosci 269","DOI":"10.1037\/t58215-000"},{"issue":"8","key":"451_CR84","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nrn3530","volume":"14","author":"DJ Nutt","year":"2013","unstructured":"Nutt DJ, King LA, Nichols DE (2013) Effects of schedule I drug laws on neuroscience research and treatment innovation. Nat Rev Neurosci 14(8):577\u2013585. https:\/\/doi.org\/10.1038\/nrn3530","journal-title":"Nat Rev Neurosci"},{"issue":"3","key":"451_CR85","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/jmt\/thaa006","volume":"57","author":"C O\u2019Callaghan","year":"2020","unstructured":"O\u2019Callaghan C, Hubik DJ, Dwyer J, Williams M, Ross M (2020) Experience of music used with psychedelic therapy: a rapid review and implications. J Music Ther 57(3):282\u2013314","journal-title":"J Music Ther"},{"issue":"3","key":"451_CR86","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1021\/acs.biochem.1c00812","volume":"61","author":"DE Olson","year":"2022","unstructured":"Olson DE (2022) Biochemical mechanisms underlying psychedelic-induced neuroplasticity. Biochemistry 61(3):127\u2013136. https:\/\/doi.org\/10.1021\/acs.biochem.1c00812","journal-title":"Biochemistry"},{"key":"451_CR87","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1590\/1516-4446-2014-1496","volume":"37","author":"F d L Os\u00f3rio","year":"2015","unstructured":"Os\u00f3rio F d L, Sanches RF, Macedo LR, Dos Santos RG, Maia-de-Oliveira JP, Wichert-Ana L, De Araujo DB, Riba J, Crippa JA, Hallak JE (2015) Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report. Braz J Psychiatry 37:13\u201320","journal-title":"Braz J Psychiatry"},{"issue":"2","key":"451_CR88","doi-asserted-by":"publisher","first-page":"e0118143","DOI":"10.1371\/journal.pone.0118143","volume":"10","author":"F Palhano-Fontes","year":"2015","unstructured":"Palhano-Fontes F, Andrade KC, Tofoli LF, Santos AC, Crippa JA, Hallak JE, Ribeiro S, de Araujo DB (2015) The psychedelic state induced by ayahuasca modulates the activity and connectivity of the default mode network. PloS One 10(2):e0118143. https:\/\/doi.org\/10.1371\/journal.pone.0118143","journal-title":"PloS One"},{"issue":"4","key":"451_CR89","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1017\/S0033291718001356","volume":"49","author":"F Palhano-Fontes","year":"2019","unstructured":"Palhano-Fontes F, Barreto D, Onias H, Andrade KC, Novaes MM, Pessoa JA, Mota-Rolim SA, Os\u00f3rio FL, Sanches R, Dos Santos RG (2019a) Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial. Psychol Med 49(4):655\u2013663","journal-title":"Psychol Med"},{"issue":"4","key":"451_CR505","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1017\/S0033291718001356","volume":"49","author":"F Palhano-Fontes","year":"2019","unstructured":"Palhano-Fontes F, Barreto D, Onias H, Andrade KC, Novaes MM, Pessoa JA, Mota-Rolim SA, Os\u00f3rio FL, Sanches R, Dos Santos RG, T\u00f3foli LF, de Oliveira G, Silveira MY, Riba J, Santos FR, Silva-Junior AA, Alchieri JC, Galv\u00e3o-Coelho NL, Lob\u00e3o-Soares B, Hallak JEC, Arcoverde E, Maia-de-Oliveira JP, Ara\u00fajo DB (2019b) Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial. Psychol Med 49(4):655\u2013663. https:\/\/doi.org\/10.1017\/S0033291718001356. Epub 2018 Jun 15. PMID: 29903051. PMCID: PMC6378413","journal-title":"Psychol Med"},{"issue":"4","key":"451_CR90","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1017\/s0033291718001356","volume":"49","author":"F Palhano-Fontes","year":"2019","unstructured":"Palhano-Fontes, F., Barreto, D., Onias, H., Andrade, K. C., Novaes, M. M., Pessoa, J. A., Mota-Rolim, S. A., Os\u00f3rio, F. L., Sanches, R., Dos Santos, R. G., T\u00f3foli, L. F., de Oliveira Silveira, G., Yonamine, M., Riba, J., Santos, F. R., Silva-Junior, A. A., Alchieri, J. C., Galv\u00e3o-Coelho, N. L., Lob\u00e3o-Soares, B., . . . Ara\u00fajo, D. B. (2019b). Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial. Psychol Med, 49(4), 655\u2013663. https:\/\/doi.org\/10.1017\/s0033291718001356","journal-title":"Psychol Med"},{"issue":"1","key":"451_CR91","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/02698811211066709","volume":"36","author":"JM Peill","year":"2022","unstructured":"Peill JM, Trinci KE, Kettner H, Mertens LJ, Roseman L, Timmermann C, Rosas FE, Lyons T, Carhart-Harris RL (2022) Validation of the psychological insight scale: a new scale to assess psychological insight following a psychedelic experience. J Psychopharmacol 36(1):31\u201345","journal-title":"J Psychopharmacol"},{"issue":"101","key":"451_CR92","doi-asserted-by":"crossref","first-page":"20140873","DOI":"10.1098\/rsif.2014.0873","volume":"11","author":"G Petri","year":"2014","unstructured":"Petri G, Expert P, Turkheimer F, Carhart-Harris R, Nutt D, Hellyer PJ, Vaccarino F (2014) Homological scaffolds of brain functional networks. J R Soc Interface 11(101):20140873","journal-title":"J R Soc Interface"},{"key":"451_CR93","doi-asserted-by":"publisher","unstructured":"Preller KH, Burt JB, Ji JL, Schleifer CH, Adkinson BD, St\u00e4mpfli P, Seifritz E, Repovs G, Krystal JH, Murray JD, Vollenweider FX, Anticevic A (2018) Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor. eLife 7. https:\/\/doi.org\/10.7554\/eLife.35082","DOI":"10.7554\/eLife.35082"},{"issue":"2","key":"451_CR94","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.biopsych.2019.12.027","volume":"88","author":"KH Preller","year":"2020","unstructured":"Preller KH, Duerler P, Burt JB, Ji JL, Adkinson B, St\u00e4mpfli P, Seifritz E, Repov\u0161 G, Krystal JH, Murray JD (2020) Psilocybin induces time-dependent changes in global functional connectivity. Biol Psychiatry 88(2):197\u2013207","journal-title":"Biol Psychiatry"},{"issue":"3","key":"451_CR95","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/npp.2011.228","volume":"37","author":"BB Quednow","year":"2012","unstructured":"Quednow BB, Kometer M, Geyer MA, Vollenweider FX (2012) Psilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteers. Neuropsychopharmacology 37(3):630\u2013640","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"451_CR96","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1001\/archpsyc.1987.01800150071009","volume":"44","author":"FM Quitkin","year":"1987","unstructured":"Quitkin FM, Rabkin JD, Markowitz JM, Stewart JW, McGrath PJ, Harrison W (1987) Use of pattern analysis to identify true drug response: a replication. Arch Gen Psychiatry 44(3):259\u2013264","journal-title":"Arch Gen Psychiatry"},{"key":"451_CR97","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3389\/fnhum.2014.00204","volume":"8","author":"L Roseman","year":"2014","unstructured":"Roseman L, Leech R, Feilding A, Nutt DJ, Carhart-Harris RL (2014) The effects of psilocybin and MDMA on between-network resting state functional connectivity in healthy volunteers. Front Hum Neurosci 8:204","journal-title":"Front Hum Neurosci"},{"key":"451_CR98","doi-asserted-by":"crossref","first-page":"974","DOI":"10.3389\/fphar.2017.00974","volume":"8","author":"L Roseman","year":"2018","unstructured":"Roseman L, Nutt DJ, Carhart-Harris RL (2018) Quality of acute psychedelic experience predicts therapeutic efficacy of psilocybin for treatment-resistant depression. Front Pharmacol 8:974","journal-title":"Front Pharmacol"},{"issue":"9","key":"451_CR99","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1177\/0269881119855974","volume":"33","author":"L Roseman","year":"2019","unstructured":"Roseman L, Haijen E, Idialu-Ikato K, Kaelen M, Watts R, Carhart-Harris R (2019) Emotional breakthrough and psychedelics: validation of the emotional breakthrough inventory. J Psychopharmacol 33(9):1076\u20131087","journal-title":"J Psychopharmacol"},{"issue":"12","key":"451_CR100","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1177\/0269881116675512","volume":"30","author":"S Ross","year":"2016","unstructured":"Ross S, Bossis A, Guss J, Agin-Liebes G, Malone T, Cohen B, Mennenga SE, Belser A, Kalliontzi K, Babb J (2016a) Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. J Psychopharmacol 30(12):1165\u20131180","journal-title":"J Psychopharmacol"},{"issue":"12","key":"451_CR101","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1177\/0269881116675512","volume":"30","author":"S Ross","year":"2016","unstructured":"Ross S, Bossis A, Guss J, Agin-Liebes G, Malone T, Cohen B, Mennenga SE, Belser A, Kalliontzi K, Babb J, Su Z, Corby P, Schmidt BL (2016b) Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. J Psychopharmacol 30(12):1165\u20131180. https:\/\/doi.org\/10.1177\/0269881116675512","journal-title":"J Psychopharmacol"},{"issue":"2","key":"451_CR102","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1177\/0269881120928203","volume":"35","author":"AV Roy","year":"2021","unstructured":"Roy AV, Thai M, Klimes-Dougan B, Westlund Schreiner M, Mueller BA, Albott CS, Lim KO, Fiecas M, Tye SJ, Cullen KR (2021) Brain entropy and neurotrophic molecular markers accompanying clinical improvement after ketamine: preliminary evidence in adolescents with treatment-resistant depression. J Psychopharmacol 35(2):168\u2013177. https:\/\/doi.org\/10.1177\/0269881120928203","journal-title":"J Psychopharmacol"},{"issue":"5","key":"451_CR103","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0006-3223(02)01866-8","volume":"54","author":"AJ Rush","year":"2003","unstructured":"Rush AJ, Trivedi MH, Ibrahim HM, Carmody TJ, Arnow B, Klein DN, Markowitz JC, Ninan PT, Kornstein S, Manber R (2003) The 16-item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry 54(5):573\u2013583","journal-title":"Biol Psychiatry"},{"issue":"1","key":"451_CR104","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/JCP.0000000000000436","volume":"36","author":"RF Sanches","year":"2016","unstructured":"Sanches RF, de Lima Os\u00f3rio F, Dos Santos RG, Macedo LR, Maia-de-Oliveira JP, Wichert-Ana L, de Araujo DB, Riba J, Crippa JAS, Hallak JE (2016) Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a SPECT study. J Clin Psychopharmacol 36(1):77\u201381","journal-title":"J Clin Psychopharmacol"},{"issue":"1","key":"451_CR105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep46421","volume":"7","author":"MM Schartner","year":"2017","unstructured":"Schartner MM, Carhart-Harris RL, Barrett AB, Seth AK, Muthukumaraswamy SD (2017a) Increased spontaneous MEG signal diversity for psychoactive doses of ketamine, LSD and psilocybin. Sci Rep 7(1):1\u201312","journal-title":"Sci Rep"},{"key":"451_CR106","doi-asserted-by":"publisher","first-page":"46421","DOI":"10.1038\/srep46421","volume":"7","author":"MM Schartner","year":"2017","unstructured":"Schartner MM, Carhart-Harris RL, Barrett AB, Seth AK, Muthukumaraswamy SD (2017b) Increased spontaneous MEG signal diversity for psychoactive doses of ketamine, LSD and psilocybin. Sci Rep 7:46421. https:\/\/doi.org\/10.1038\/srep46421","journal-title":"Sci Rep"},{"key":"451_CR107","doi-asserted-by":"crossref","unstructured":"Sloshower J, Skosnik PD, Safi-Aghdam H, Pathania S, Syed S, Pittman B, D\u2019Souza DC (2023) Psilocybin-assisted therapy for major depressive disorder: an exploratory placebo-controlled, fixed-order trial. J Psychopharmacol:02698811231154852","DOI":"10.1177\/02698811231154852"},{"key":"451_CR108","doi-asserted-by":"crossref","unstructured":"Spielberger CD (1983) State-trait anxiety inventory for adults","DOI":"10.1037\/t06496-000"},{"key":"451_CR109","unstructured":"Stace WT (1960) Mysticism and philosophy. Philosophy 37(140)"},{"issue":"8","key":"451_CR110","doi-asserted-by":"crossref","first-page":"e12412","DOI":"10.1371\/journal.pone.0012412","volume":"5","author":"E Studerus","year":"2010","unstructured":"Studerus E, Gamma A, Vollenweider FX (2010) Psychometric evaluation of the altered states of consciousness rating scale (OAV). PloS One 5(8):e12412","journal-title":"PloS One"},{"issue":"3","key":"451_CR111","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1037\/a0037512","volume":"24","author":"JK Swift","year":"2014","unstructured":"Swift JK, Greenberg RP (2014) A treatment by disorder meta-analysis of dropout from psychotherapy. J Psychother Integr 24(3):193","journal-title":"J Psychother Integr"},{"key":"451_CR112","doi-asserted-by":"publisher","unstructured":"Szigeti B, Kartner L, Blemings A, Rosas F, Feilding A, Nutt DJ, Carhart-Harris RL, Erritzoe D (2021) Self-blinding citizen science to explore psychedelic microdosing. eLife 10. https:\/\/doi.org\/10.7554\/eLife.62878","DOI":"10.7554\/eLife.62878"},{"key":"451_CR504","doi-asserted-by":"publisher","unstructured":"Szigeti B, Nutt D, Carhart-Harris R, Erritzoe D (2023) The difference between \u2018placebo group\u2019 and \u2018placebo control\u2019: a case study in psychedelic icrodosing. Sci Rep 13. https:\/\/doi.org\/10.1038\/s41598-023-34938-7","DOI":"10.1038\/s41598-023-34938-7"},{"issue":"8","key":"451_CR114","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.cub.2016.02.010","volume":"26","author":"E Tagliazucchi","year":"2016","unstructured":"Tagliazucchi E, Roseman L, Kaelen M, Orban C, Muthukumaraswamy SD, Murphy K, Laufs H, Leech R, McGonigle J, Crossley N (2016) Increased global functional connectivity correlates with LSD-induced ego dissolution. Curr Biol 26(8):1043\u20131050","journal-title":"Curr Biol"},{"key":"451_CR115","doi-asserted-by":"crossref","first-page":"720066","DOI":"10.3389\/fpsyt.2021.720066","volume":"12","author":"E Tagliazucchi","year":"2021","unstructured":"Tagliazucchi E, Zamberlan F, Cavanna F, de la Fuente L, Romero C, Sanz Perl Y, Pallavicini C (2021) Baseline power of theta oscillations predicts mystical-type experiences induced by DMT in a natural setting. Front Psych 12:720066","journal-title":"Front Psych"},{"issue":"11","key":"451_CR116","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1001\/archpsyc.63.11.1217","volume":"63","author":"MJ Taylor","year":"2006","unstructured":"Taylor MJ, Freemantle N, Geddes JR, Bhagwagar Z (2006) Early onset of selective serotonin reuptake inhibitor antidepressant action: systematic review and meta-analysis. Arch Gen Psychiatry 63(11):1217\u20131223. https:\/\/doi.org\/10.1001\/archpsyc.63.11.1217","journal-title":"Arch Gen Psychiatry"},{"key":"451_CR117","unstructured":"Team, D. R. S. S. (2003) GRID-HAMD-17, GRID-HAMD-21 structured interview guide. In: International society for CNS drug development San Diego"},{"issue":"1","key":"451_CR118","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/02698811211008554","volume":"36","author":"PJ Teixeira","year":"2022","unstructured":"Teixeira PJ, Johnson MW, Timmermann C, Watts R, Erritzoe D, Douglass H, Kettner H, Carhart-Harris RL (2022) Psychedelics and health behaviour change. J Psychopharmacol 36(1):12\u201319","journal-title":"J Psychopharmacol"},{"issue":"1","key":"451_CR119","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-51974-4","volume":"9","author":"C Timmermann","year":"2019","unstructured":"Timmermann C, Roseman L, Schartner M, Milliere R, Williams LT, Erritzoe D, Muthukumaraswamy S, Ashton M, Bendrioua A, Kaur O (2019) Neural correlates of the DMT experience assessed with multivariate EEG. Sci Rep 9(1):1\u201313","journal-title":"Sci Rep"},{"issue":"13","key":"451_CR120","doi-asserted-by":"publisher","first-page":"e2218949120","DOI":"10.1073\/pnas.2218949120","volume":"120","author":"C Timmermann","year":"2023","unstructured":"Timmermann C, Roseman L, Haridas S, Rosas FE, Luan L, Kettner H, Martell J, Erritzoe D, Tagliazucchi E, Pallavicini C, Girn M, Alamia A, Leech R, Nutt DJ, Carhart-Harris RL (2023) Human brain effects of DMT assessed via EEG-fMRI. Proc Natl Acad Sci U S A 120(13):e2218949120. https:\/\/doi.org\/10.1073\/pnas.2218949120","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6633","key":"451_CR121","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1126\/science.adf0435","volume":"379","author":"MV Vargas","year":"2023","unstructured":"Vargas MV, Dunlap LE, Dong C, Carter SJ, Tombari RJ, Jami SA, Cameron LP, Patel SD, Hennessey JJ, Saeger HN (2023) Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors. Science 379(6633):700\u2013706","journal-title":"Science"},{"issue":"1","key":"451_CR122","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-06854-0","volume":"7","author":"A Viol","year":"2017","unstructured":"Viol A, Palhano-Fontes F, Onias H, de Araujo DB, Viswanathan G (2017) Shannon entropy of brain functional complex networks under the influence of the psychedelic Ayahuasca. Sci Rep 7(1):1\u201313","journal-title":"Sci Rep"},{"issue":"5","key":"451_CR123","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1177\/0022167817709585","volume":"57","author":"R Watts","year":"2017","unstructured":"Watts R, Day C, Krzanowski J, Nutt D, Carhart-Harris R (2017) Patients\u2019 accounts of increased \u201cconnectedness\u201d and \u201cacceptance\u201d after psilocybin for treatment-resistant depression. J Humanist Psychol 57(5):520\u2013564","journal-title":"J Humanist Psychol"},{"issue":"1","key":"451_CR124","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-79139-8","volume":"11","author":"B Weiss","year":"2021","unstructured":"Weiss B, Miller JD, Carter NT, Keith Campbell W (2021) Examining changes in personality following shamanic ceremonial use of ayahuasca. Sci Rep 11(1):1\u201315","journal-title":"Sci Rep"},{"key":"451_CR125","unstructured":"Weiss B et al (under review) Unique psychological mechanisms in the treatment of major depressive disorder underlying psilocybin therapy versus escitalopram treatment. Int J Ment Heal Addict"},{"issue":"4","key":"451_CR126","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1017\/S096318012200007X","volume":"31","author":"DB Yaden","year":"2022","unstructured":"Yaden DB, Earp BD, Griffiths RR (2022) Ethical issues regarding nonsubjective psychedelics as standard of care. Camb Q Healthc Ethics 31(4):464\u2013471","journal-title":"Camb Q Healthc Ethics"},{"issue":"9","key":"451_CR127","doi-asserted-by":"crossref","first-page":"e0133775","DOI":"10.1371\/journal.pone.0133775","volume":"10","author":"M Ye","year":"2015","unstructured":"Ye M, Yang T, Qing P, Lei X, Qiu J, Liu G (2015) Changes of functional brain networks in major depressive disorder: a graph theoretical analysis of resting-state fMRI. PloS One 10(9):e0133775","journal-title":"PloS One"},{"key":"451_CR128","doi-asserted-by":"crossref","unstructured":"Zeifman RJ, Wagner AC, Watts R, Kettner H, Mertens LJ, Carhart-Harris RL (2020) Post-psychedelic reductions in experiential avoidance are associated with decreases in depression severity and suicidal ideation. Front Psych:782","DOI":"10.3389\/fpsyt.2020.00782"},{"issue":"2","key":"451_CR129","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s00213-020-05692-9","volume":"238","author":"RJ Zeifman","year":"2021","unstructured":"Zeifman RJ, Singhal N, Dos Santos RG, Sanches RF, de Lima Os\u00f3rio F, Hallak JEC, Weissman CR (2021) Rapid and sustained decreases in suicidality following a single dose of ayahuasca among individuals with recurrent major depressive disorder: results from an open-label trial. Psychopharmacology (Berl) 238(2):453\u2013459. https:\/\/doi.org\/10.1007\/s00213-020-05692-9","journal-title":"Psychopharmacology (Berl)"}],"container-title":["Current Topics in Behavioral Neurosciences","Emerging Neurobiology of Antidepressant Treatments"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/7854_2023_451","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T16:43:17Z","timestamp":1721839397000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/7854_2023_451"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"ISBN":["9783031663550","9783031663567"],"references-count":134,"URL":"https:\/\/doi.org\/10.1007\/7854_2023_451","relation":{},"ISSN":["1866-3370","1866-3389"],"issn-type":[{"value":"1866-3370","type":"print"},{"value":"1866-3389","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"14 November 2023","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}